Stefan
A bit of perspective.
The company is focused on developing the next generation product.
What is the point of marketing the old generation, when the next generation is full of the features that the users want?
They have been engaged in refining and adapting the product and I personally couldn't be happier.
The CCE mob went about marketing the wrong way, not getting the detail right and then destroying the credibility of the company.
As far as I'm concerned, Dolphin has his priorities correct and things are lining up for FDA approval to coincide with the launch of the next generation product.
There is no point in looking at sales figures in isolation. This is a developing company, with a massive future. If you've lost patience, fine, but don't bombard us with misleading information taken out of context.
DV
- Forums
- ASX - By Stock
- AVH
- this is rubbish
this is rubbish, page-6
-
- There are more pages in this discussion • 56 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVH (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.82 |
Change
0.140(3.80%) |
Mkt cap ! $266.9M |
Open | High | Low | Value | Volume |
$3.83 | $3.87 | $3.77 | $1.433M | 374.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3987 | $3.82 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.86 | 200 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3987 | 3.820 |
2 | 860 | 3.800 |
1 | 4 | 3.780 |
1 | 2000 | 3.770 |
1 | 7963 | 3.760 |
Price($) | Vol. | No. |
---|---|---|
3.860 | 200 | 1 |
3.870 | 9629 | 2 |
3.880 | 17056 | 3 |
3.890 | 6504 | 2 |
3.900 | 8380 | 3 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online